HERON THERAPEUTICS, INC. /DE/ Operating Lease Liability
HERON THERAPEUTICS, INC. /DE/ (HRTX) had Operating Lease Liability of $5.70 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-10
- 2026-06-30: Operating Lease, Liability $5.70M.
- 2025-09-30: Operating Lease, Liability $780.00K.
- 2025-06-30: Operating Lease, Liability $1.54M.
- 2025-03-31: Operating Lease, Liability $2.29M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $5.70M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $780.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $1.54M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $2.29M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $3.04M 10-K · filed 2025-02-27 |
| 2024-09-30 | $3.77M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $4.48M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $5.18M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $5.88M 10-K · filed 2024-03-12 |
| 2023-09-30 | $6.54M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $6.74M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $7.59M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $8.19M 10-K · filed 2023-03-29 |
| 2022-09-30 | $8.77M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $9.33M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $9.88M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $10.41M 10-K · filed 2022-02-28 |
| 2021-09-30 | $15.47M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $16.18M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $16.87M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $17.56M 10-K · filed 2021-02-24 |
| 2020-09-30 | $18.21M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $18.84M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $19.46M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $14.17M 10-K · filed 2020-03-02 |
| 2019-09-30 | $12.50M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $12.97M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $13.76M 10-Q · filed 2019-05-09 |
| 2019-01-01 | $14.50M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |